Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 7635.0 | 50 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-8 | 9338.0 | 64 | |
N2586 | PI103 | 0.1 | uM | 3 | IL-8 | 603.0 | 93 | ||||
0 | IL-8 | 13.0 | 65 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IL-8 | 9459.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 6934.0 | 55 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 7002.0 | 73 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 12594.0 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 10695.0 | 71 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 3205.0 | 72 | |
RA2159 | EO1428 | 1.0 | uM | 3 | IL-8 | 655.5 | 62 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | IL-8 | 10872.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 10403.0 | 67 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 8691.5 | 80 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 444.0 | 68 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 5657.0 | 77 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-8 | 11005.5 | 72 | |
N2586 | EO1428 | 1.0 | uM | 3 | IL-8 | 842.0 | 72 | ||||
0 | IL-8 | 13.0 | 43 | ||||||||
RA2159 | 3 | IL-8 | 223.0 | 77 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-8 | 387.0 | 69 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-8 | 351.0 | 81 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-8 | 592.5 | 64 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-8 | 686.0 | 46 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-8 | 235.5 | 74 |